AI algorithm for detection of AAA nets FDA clearance
Click Here to Manage Email Alerts
Viz.ai announced it received FDA 510(k) clearance for its artificial intelligence algorithm for the detection and triage of suspected abdominal aortic aneurysm from any chest CT scan.
The new AI algorithm and clinical workflow solution (Viz AAA) will be a part of a module (Viz AORTIC Module) to accelerate treatment decisions for all aortic pathology, according to a press release from the company.
Image: Adobe Stock
The algorithm can be integrated into existing hospital workflows, allowing physicians to identify patients with suspected AAA and take measures to prevent rupture, according to the release.
“There is an estimated 1.1 million Americans living with an AAA. Majority of these patients are asymptomatic and many are unaware of their disease until a rupture occurs. This is a catastrophic medical emergency, resulting in over 10,000 deaths each year,” Philip Batista, MD, associate program director of the vascular and endovascular surgery residency at Cooper University Health Care in the Camden, New Jersey area, said in the release. “This algorithm is a powerful new tool for health care professionals to more readily identify and capture individuals with AAA and, importantly, automatically refer those at imminent risk for rupture.”
Collapse
Click Here to Manage Email Alerts